Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.

Nguyen, Austin Huy

Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review. [electronic resource] - Anticancer research 01 2017 - 1-7 p. digital

Publication Type: Journal Article; Review; Systematic Review

1791-7530

10.21873/anticanres.11282 doi


Animals
Biomarkers, Tumor--metabolism
Carcinoma, Basal Cell--metabolism
Carcinoma, Squamous Cell--metabolism
Cell Transformation, Neoplastic--metabolism
HMGB1 Protein--metabolism
Humans
Inflammation Mediators--metabolism
Melanoma--metabolism
Predictive Value of Tests
Prognosis
Receptor for Advanced Glycation End Products--metabolism
Risk Factors
Signal Transduction
Skin Neoplasms--metabolism